Overactive Bladder

What Is New in Neuromodulation for Overactive Bladder? May 29, 2018

Metabolomic Analysis of Overactive Bladder in Male Patients: Identification of Potential Metabolite Biomarkers. May 29, 2018

A prospective, non-intErventional registry study of PatiEnts initiating a course of drug therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. May 28, 2018

Women undergoing third line overactive bladder treatment demonstrate elevated thermal temporal summation. May 15, 2018

Review of Economic Value Drivers of the Treatment of Overactive Bladder. May 15, 2018

Treatment of Non-neurogenic Overactive Bladder with OnabotulinumtoxinA: Systematic Review and Meta-analysis of Prospective, Randomized, Placebo-controlled Clinical Trials. May 12, 2018

Transcutaneous tibial nerve stimulation: 2 years follow-up outcomes in the management of anticholinergic refractory overactive bladder. May 7, 2018

Mirabegron 25 Mg Monotherapy is Safe but Less Effective in Male Overactive Bladder Patients with Bladder Outlet Obstruction. May 7, 2018

Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. May 7, 2018

Basic and clinical aspects of Antimuscarinic agents used to treat overactive bladder. May 6, 2018

Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. May 4, 2018

Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis. May 1, 2018

Efficacy and safety of mirabegron, a β3 -adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. May 1, 2018

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK. May 1, 2018

Overactive bladder induces transient hypertension. April 30, 2018

The importance of uterosacral ligament anatomy in overactive bladder: A preliminary study. April 28, 2018

Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients. April 28, 2018

Beta-3 adrenoceptor expression in the uterosacral ligament in the postmenopausal women with pelvic organ prolapse. April 28, 2018

Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand? April 28, 2018

Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality? April 28, 2018

Page 1 of 73